An antivector vaccine protects against a lethal vector-borne pathogen.
about
Salp15 binding to DC-SIGN inhibits cytokine expression by impairing both nucleosome remodeling and mRNA stabilizationCrystal structure and functional characterization of an immunomodulatory salivary cystatin from the soft tick Ornithodoros moubataThe enhancement of arbovirus transmission and disease by mosquito saliva is associated with modulation of the host immune responseArbovirosis and potential transmission blocking vaccinesVaccines and immunization strategies for dengue preventionEmerging horizons for tick-borne pathogens: from the 'one pathogen-one disease' vision to the pathobiome paradigmA clear and present danger: tick-borne diseases in EuropeChanges in the Proteome of Langat-Infected Ixodes scapularis ISE6 Cells: Metabolic Pathways Associated with Flavivirus InfectionA chronological review of experimental infection studies of the role of wild animals and livestock in the maintenance and transmission of Crimean-Congo hemorrhagic fever virusDifferential expression of genes in salivary glands of male Rhipicephalus (Boophilus)microplus in response to infection with Anaplasma marginale.Salivating for knowledge: potential pharmacological agents in tick salivaImmunity to distinct sand fly salivary proteins primes the anti-Leishmania immune response towards protection or exacerbation of disease.Antibodies against a tick protein, Salp15, protect mice from the Lyme disease agentTick histamine release factor is critical for Ixodes scapularis engorgement and transmission of the lyme disease agentFlipping the paradigm on malaria transmission-blocking vaccines.Differential salivary gland transcript expression profile in Ixodes scapularis nymphs upon feeding or flavivirus infectionVaccination against Lyme disease: past, present, and futureAlkhurma viral hemorrhagic fever virus: proposed guidelines for detection, prevention, and control in Saudi Arabia.Implication of haematophagous arthropod salivary proteins in host-vector interactionsVaccination against Bm86 Homologues in Rabbits Does Not Impair Ixodes ricinus Feeding or OvipositionTransmission-Blocking Vaccines: Focus on Anti-Vector Vaccines against Tick-Borne DiseasesImmunity against Ixodes scapularis salivary proteins expressed within 24 hours of attachment thwarts tick feeding and impairs Borrelia transmission.Saliva from nymph and adult females of Haemaphysalis longicornis: a proteomic studyImpact of climate trends on tick-borne pathogen transmissionIxodes scapularis saliva mitigates inflammatory cytokine secretion during Anaplasma phagocytophilum stimulation of immune cells.Immunization with Culex tarsalis mosquito salivary gland extract modulates West Nile virus infection and disease in miceImmunity to a salivary protein of a sand fly vector protects against the fatal outcome of visceral leishmaniasis in a hamster model.The skin as interface in the transmission of arthropod-borne pathogens.Cutting edge: Immunity against a "silent" salivary antigen of the Lyme vector Ixodes scapularis impairs its ability to feedTaking a bite out of vector-transmitted infectious diseases.Tick vaccines and the control of tick-borne pathogens.Anaplasma phagocytophilum--a widespread multi-host pathogen with highly adaptive strategies.Induction of humoral immune response to multiple recombinant Rhipicephalus appendiculatus antigens and their effect on tick feeding success and pathogen transmission.Tick-borne disease systems emerge from the shadows: the beauty lies in molecular detail, the message in epidemiology.ANTIDotE: anti-tick vaccines to prevent tick-borne diseases in Europe.Oral vaccination with vaccinia virus expressing the tick antigen subolesin inhibits tick feeding and transmission of Borrelia burgdorferiA new method for in vitro feeding of Rhipicephalus australis (formerly Rhipicephalus microplus) larvae: a valuable tool for tick vaccine development.Anaplasma marginale and Anaplasma phagocytophilum: Rickettsiales pathogens of veterinary and public health significance.Tick-Borne Viruses and Biological Processes at the Tick-Host-Virus Interface.Emerging Tick-Borne Viruses in the Twenty-First Century.
P2860
Q21559503-041611F1-2B85-4995-BB51-AEDE5F53FC4BQ24599696-1BC91AA7-06C6-41D6-A49E-AC553B2F2CC9Q24657806-16C05596-2687-4E46-89CA-298BF2EB55E6Q27468657-C81C461B-13E5-45FF-8BA4-A659F5ECA838Q28077521-4C7CB8FC-48B7-44B8-91C9-B6DDE77F8738Q28085222-06340AAB-042D-499B-AF88-4E0B1DEC2AE1Q28267851-7768BF3E-2CC9-47C2-8943-0B893F757494Q28550057-983392C1-7311-4EC8-8B39-657673A3E18AQ30244052-5FEC12B0-92C0-4B8B-AC07-F64B3B263C27Q30979683-08ECF332-18D6-441A-88D9-D83EF355121DQ33319614-05E26D44-ACAD-4FA5-B174-CBD0115E4138Q33328462-7E7E1D0D-99A9-4219-8024-C134BB157D4AQ33745554-D8D5A117-3050-4805-BC0F-6B0633A4DFD9Q33760842-3A3F5CA1-2678-4E42-90C5-C6846467720AQ34128872-FEA41E39-7998-48CF-BB91-7934F82DDAE7Q34152051-92F70B62-A0EC-452F-A4C9-2E11F25FDC3AQ34327726-C15B152D-9AAD-4925-A166-FB22982E8D69Q34364941-C64BC463-1661-4EAC-B725-705086A13526Q35398192-D4F07D71-D61C-47BC-BBFB-9501150D71F9Q35547214-46B2DC85-27AE-4034-A6CC-8EA56D42F52AQ35598662-603FDC48-3334-4EBF-A50A-A7823BC191D8Q35785483-6955706C-51C4-4455-889C-A0C0E3880E25Q35794429-B742A3A3-1622-47B7-84B1-CEC41BE58960Q35855316-DC176491-F649-4D48-9DFC-02DE898CE772Q36416025-B647A895-AE97-4A97-A066-22C5EEF474C7Q36626730-D8A10CB0-F441-4959-B18F-1FD5CAF36895Q36678092-996D35E1-1F7E-4048-A7A0-CEA32E2AD362Q36816174-7E8E098A-F5FB-452A-9A71-0C5522308E06Q36924451-53A7EA07-3285-4448-8971-EAC71BA3C2A9Q36958648-94E94389-92D1-4FC3-BB9A-435A03191C31Q36993703-FA8E2CA5-2787-4596-ACAE-1502D31CFD5EQ37030096-4F1523EC-D06C-4930-AE2D-2C50021EFEDCQ37230869-C7110909-FF59-43EE-BC14-C7224D17EC75Q37444237-810FBFF5-F6A7-4843-A027-DF5153130A16Q37600954-7D147962-D923-46D4-8092-0B10F3B78F2EQ37610717-CF3EA8A9-F476-4FCE-A798-2BDC0B545A39Q37719643-5F6A3E65-B2BD-4ADC-9E72-E27CA15A2516Q38582477-DD313BE8-D269-4898-BD66-4DC58297036AQ38644037-1125A847-F617-4704-BFC0-C0D07022DA23Q38651761-EF7A0060-2F7D-4939-9A19-539583EA5B5C
P2860
An antivector vaccine protects against a lethal vector-borne pathogen.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
An Antivector Vaccine Protects against a Lethal Vector-Borne Pathogen
@nl
An antivector vaccine protects against a lethal vector-borne pathogen.
@ast
An antivector vaccine protects against a lethal vector-borne pathogen.
@en
type
label
An Antivector Vaccine Protects against a Lethal Vector-Borne Pathogen
@nl
An antivector vaccine protects against a lethal vector-borne pathogen.
@ast
An antivector vaccine protects against a lethal vector-borne pathogen.
@en
prefLabel
An Antivector Vaccine Protects against a Lethal Vector-Borne Pathogen
@nl
An antivector vaccine protects against a lethal vector-borne pathogen.
@ast
An antivector vaccine protects against a lethal vector-borne pathogen.
@en
P2093
P2860
P3181
P1433
P1476
An antivector vaccine protects against a lethal vector-borne pathogen.
@en
P2093
Adama R Trimnell
Gillian M Davies
Martina Licková
Milan Labuda
Mária Kazimírová
Olga Lissina
Patricia A Nuttall
Rosie S Hails
P2860
P3181
P356
10.1371/JOURNAL.PPAT.0020027
P577
2006-04-07T00:00:00Z